Matches in SemOpenAlex for { <https://semopenalex.org/work/W24722359> ?p ?o ?g. }
- W24722359 endingPage "4680" @default.
- W24722359 startingPage "4672" @default.
- W24722359 abstract "Among a series of fucolipids accumulating in human colonic and liver adenocarcinoma, two neutral fucolipids have been isolated and their carbohydrate structures have been characterized by methylation analysis, mass spectrometry, enzymatic degradation, and proton NMR spectrometry as shown in Structures 1 and 2 below. These glycolipids are either absent or present in very small quantity in normal colonic mucosa and normal liver tissue. (formular; see text) Difucosyl neolactonorhexaosylceramide (Structure 1) gives a doublet or a triplet on high performance thin layer chromatography and can be separated into four to five fractions on high pressure high performance liquid chromatography. These components have the same carbohydrate structure, but have different fatty acid composition. Fractions are characterized by a predominance of either alpha-hydroxy C16 fatty acid or alpha-hydroxy C24 fatty acid. Trifucosyl neolactonoroctaosylceramide (structure 2) gives two discrete bands, which are designated Z3 and Z4, on high performance thin layer chromatography. Methylation analysis and nuclear magnetic resonance spectra show that the Z3 and Z4 have identical carbohydrate structures. All the cases of cancer tissue that accumulate di- or trifucosyl structure (1 or 2 above) also accumulated lactofucopentaose(III)ceramide. A possible enhancement in a specific synthetic pathway including type 2 chain elongation coupled with alpha 1----3 fucosylation in human cancer is discussed." @default.
- W24722359 created "2016-06-24" @default.
- W24722359 creator A5005032064 @default.
- W24722359 creator A5027786827 @default.
- W24722359 creator A5051369410 @default.
- W24722359 creator A5070398233 @default.
- W24722359 date "1984-04-01" @default.
- W24722359 modified "2023-10-18" @default.
- W24722359 title "Novel fucolipids accumulating in human adenocarcinoma. I. Glycolipids with di- or trifucosylated type 2 chain." @default.
- W24722359 cites W1488620239 @default.
- W24722359 cites W1491079881 @default.
- W24722359 cites W1501733677 @default.
- W24722359 cites W1501761217 @default.
- W24722359 cites W1520466764 @default.
- W24722359 cites W1556940478 @default.
- W24722359 cites W1563976911 @default.
- W24722359 cites W1564650229 @default.
- W24722359 cites W1574988237 @default.
- W24722359 cites W1580360169 @default.
- W24722359 cites W1596051159 @default.
- W24722359 cites W1608212624 @default.
- W24722359 cites W1754937767 @default.
- W24722359 cites W1963772597 @default.
- W24722359 cites W1981984744 @default.
- W24722359 cites W1987227850 @default.
- W24722359 cites W1987628278 @default.
- W24722359 cites W1999369513 @default.
- W24722359 cites W2012643763 @default.
- W24722359 cites W2013381634 @default.
- W24722359 cites W2015657041 @default.
- W24722359 cites W2018410272 @default.
- W24722359 cites W2021570486 @default.
- W24722359 cites W2029202131 @default.
- W24722359 cites W2034917177 @default.
- W24722359 cites W2038907155 @default.
- W24722359 cites W2049565713 @default.
- W24722359 cites W2053700894 @default.
- W24722359 cites W2054941870 @default.
- W24722359 cites W2058207060 @default.
- W24722359 cites W2062329622 @default.
- W24722359 cites W2074443036 @default.
- W24722359 cites W2083983934 @default.
- W24722359 cites W2100169451 @default.
- W24722359 cites W2116850184 @default.
- W24722359 cites W2141784677 @default.
- W24722359 cites W2144999511 @default.
- W24722359 cites W2158343596 @default.
- W24722359 cites W2166715592 @default.
- W24722359 cites W2171793722 @default.
- W24722359 cites W2212219295 @default.
- W24722359 cites W2410871869 @default.
- W24722359 cites W958441418 @default.
- W24722359 doi "https://doi.org/10.1016/s0021-9258(17)43099-7" @default.
- W24722359 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6707026" @default.
- W24722359 hasPublicationYear "1984" @default.
- W24722359 type Work @default.
- W24722359 sameAs 24722359 @default.
- W24722359 citedByCount "238" @default.
- W24722359 countsByYear W247223592012 @default.
- W24722359 countsByYear W247223592013 @default.
- W24722359 countsByYear W247223592014 @default.
- W24722359 countsByYear W247223592015 @default.
- W24722359 countsByYear W247223592016 @default.
- W24722359 countsByYear W247223592017 @default.
- W24722359 countsByYear W247223592018 @default.
- W24722359 countsByYear W247223592019 @default.
- W24722359 countsByYear W247223592020 @default.
- W24722359 countsByYear W247223592021 @default.
- W24722359 countsByYear W247223592022 @default.
- W24722359 crossrefType "journal-article" @default.
- W24722359 hasAuthorship W24722359A5005032064 @default.
- W24722359 hasAuthorship W24722359A5027786827 @default.
- W24722359 hasAuthorship W24722359A5051369410 @default.
- W24722359 hasAuthorship W24722359A5070398233 @default.
- W24722359 hasBestOaLocation W247223591 @default.
- W24722359 hasConcept C121332964 @default.
- W24722359 hasConcept C1276947 @default.
- W24722359 hasConcept C153911025 @default.
- W24722359 hasConcept C185592680 @default.
- W24722359 hasConcept C199185054 @default.
- W24722359 hasConcept C22222904 @default.
- W24722359 hasConcept C55493867 @default.
- W24722359 hasConcept C86803240 @default.
- W24722359 hasConceptScore W24722359C121332964 @default.
- W24722359 hasConceptScore W24722359C1276947 @default.
- W24722359 hasConceptScore W24722359C153911025 @default.
- W24722359 hasConceptScore W24722359C185592680 @default.
- W24722359 hasConceptScore W24722359C199185054 @default.
- W24722359 hasConceptScore W24722359C22222904 @default.
- W24722359 hasConceptScore W24722359C55493867 @default.
- W24722359 hasConceptScore W24722359C86803240 @default.
- W24722359 hasIssue "7" @default.
- W24722359 hasLocation W247223591 @default.
- W24722359 hasOpenAccess W24722359 @default.
- W24722359 hasPrimaryLocation W247223591 @default.
- W24722359 hasRelatedWork W1483932958 @default.
- W24722359 hasRelatedWork W2009650314 @default.
- W24722359 hasRelatedWork W205625490 @default.